<DOC>
	<DOCNO>NCT01436591</DOCNO>
	<brief_summary>The primary endpoint study show algorithm high definition superior classical algorithm diagnosis lymph node metastasis .</brief_summary>
	<brief_title>Comparison Diagnostic Performance Algorithm High Definition Classical Iterative Algorithm Positron Emission Tomography ( PET ) 18Fluoro-deoxy-glucose ( 18FDG ) Evaluation Axillary Lymph Node Invasion Breast Tumors</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<mesh_term>Deoxyglucose</mesh_term>
	<criteria>Informed consent sign patient Age ≥ 18 year Breast tumor therapeutic indication surgery outset : breast surgery ( conservative radical ) associate conventional axillary dissection Proof infiltrate ductal carcinoma histology No know metastasis No consindication anesthesia . Exclusion criterion : History neoadjuvant therapy Patients invasive lobular carcinoma Indication use sentinel node ( invasive carcinoma unicentric , ≤ 2 cm diameter , without palpable lymphadenopathy ( N0 ) ) Diabetes controlled conventional treatment ( blood glucose &gt; 1.8 g / l ) Inability capital Patients pregnant nursing childbearing potential use adequate contraception Persons deprive liberty Major subject measure legal protection unable consent Refusal participate</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Cancer</keyword>
	<keyword>Breast</keyword>
	<keyword>18FDG</keyword>
	<keyword>Axillary</keyword>
	<keyword>Positron Emission Tomography</keyword>
</DOC>